Full-Time

Oncology Infusion Nurse

Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center

10,001+ employees

Teaching hospital delivering patient-centered medical care

Compensation Overview

$38 - $98.19/hr

+ Shift differentials + Call pay + Premium pay + Overtime pay

Boston, MA, USA

In Person

Bachelor's

Category
Medical, Clinical & Veterinary (1)
Required Skills
Care Coordination
Basic Life Support (BLS)

Get referred to Beth Israel Deaconess Medical Center

See people who can refer or advise you

Requirements
  • One to three years of related work experience is required.
  • Graduation from an accredited nursing program is required.
  • A registered nurse license is required.
  • An American Heart Association Basic Life Support certificate is required.
  • Ability to make decisions guided by general instructions and practices, including recommendations for moderately complex problems.
  • Ability to analyze varied problems using direct observation, knowledge, and skills based on general precedents.
  • Ability to follow procedures, set priorities, and organize work within general guidelines.
  • Ability to communicate clearly and effectively in written English.
  • Ability to comprehend and converse in English with medical center staff, patients, families, and external customers.
  • Working knowledge of standard concepts, practices, procedures, and policies, with the ability to apply them in varied situations.
  • Ability to provide professional, respectful, service-oriented care using active listening and problem-solving skills.
  • Ability to provide care to neonatal, young adult, middle-age, and elderly patient groups.
  • Ability to meet the physical requirements of medium work, including occasional exertion of up to 50 pounds and frequent exertion of up to 20 pounds.
  • Ability to stand or move around for most of the shift and perform the listed walking, bending, twisting, crouching, grasping, manipulation, pushing, pulling, reaching, keyboarding, lifting, and carrying activities.
  • Ability to pull up or reposition patients weighing up to 100 pounds without assistance and up to 250 pounds with assistance, and push wheelchairs or wheeled beds containing patients weighing up to 250 pounds with assistance.
  • Ability to use required protective equipment and work around infectious diseases, airborne pathogens, and bloodborne pathogens.
  • Annual influenza vaccination is required as a condition of employment.
Responsibilities
  • Provide direct nursing care to patients and families using the nursing process as the professional registered nurse framework.
  • Systematically assess the health care needs of individuals or groups and formulate, implement, and evaluate care plans.
  • Make nursing judgments by integrating theoretical knowledge with practical experience in patient care.
  • Coordinate patient care and direct assistive personnel to provide safe, effective, efficient, equitable, timely, and patient-centered care.
  • Identify resources necessary to implement plans of care and account for environmental forces affecting patients and their families.
  • Collaborate with other health professionals to determine the health care needs of patients and families.
  • Develop relationships with patients and families that maintain and communicate trust and respect.
  • Communicate effectively when exchanging information and act as a patient advocate.
  • Maintain annual mandatory education requirements, including emergency skills and unit-based competencies.
  • Identify continuing growth and development needs with the unit-based educator or clinical nurse specialist.
  • Participate in professional development activities and, when applicable, quality improvement activities.
  • Maintain responsibility and accountability for nursing practice and patient safety.
Desired Qualifications
  • A baccalaureate degree in nursing is strongly preferred.
Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center

View

Beth Israel Deaconess Medical Center (BIDMC) serves as a teaching hospital in Boston affiliated with Harvard Medical School, offering a wide range of medical services across inpatient, emergency, outpatient, and urgent care. Its care model centers on delivering high-quality medical treatment to patients, supported by patient access initiatives like OpenNotes, which lets patients view clinicians’ notes online to improve understanding and engagement in their care. The hospital also supports education and research through its affiliation with Harvard, attracting funding for studies and training programs. BIDMC differentiates itself through its patient-centered approach, active patient engagement tools, and a broad network of urgent care centers and outpatient services that extend access to healthcare. The goal is to provide comprehensive, accessible, evidence-based medical care while advancing medical education and research.

Company Size

10,001+

Company Stage

Grant

Total Funding

$5.4M

Headquarters

Boston, Massachusetts

Founded

1996

Get referred to Beth Israel Deaconess Medical Center

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BIDMC won a $1.63 million NIH R01 on June 25, 2026 for ADAMTS13 research.
  • Needham patient volume doubled over ten years, supporting a new ambulatory building.
  • BIDMC expanded NeuroXT's Alzheimer's collaboration on May 26, 2026, strengthening AI-clinical research ties.

What critics are saying

  • Vita v. BIDMC, filed February 2023, alleges website data sharing with Meta and Google.
  • Unionized residents ratified a first contract July 1, 2026, raising labor costs through 2029.
  • Needham expansion and 2031 cancer-hospital construction demand capital while reimbursement stays unforgiving.

What makes Beth Israel Deaconess Medical Center unique

  • Harvard-affiliated BIDMC drives translational research, training, and specialty care from Boston.
  • OpenNotes made BIDMC a national transparency pioneer, opening all clinicians' notes.
  • Dana-Farber collaboration anchors BIDMC in the region's only dedicated adult inpatient cancer hospital.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Boston Cambridge Biotech Networks
Sep 1st, 2026
Beth Israel Deaconess plans new building in Needham as patient volume doubles

Beth Israel Deaconess plans new building in Needham as patient volume doubles

Harvard Medical Faculty Physicians
Aug 6th, 2026
BIDMC nationally recognized by U.S. News & World Report

BIDMC nationally recognized by U.S. News & world report. BIDMC has once again been recognized as a leading hospital in Boston and the nation. The hospital was nationally ranked in eight adult specialties - OBGYN (#4), diabetes and endocrinology - BIDMC and the Joslin Diabetes Center (#9), gastroenterology and GI surgery (#26), cancer care (#28), pulmonary and lung surgery (#26), geriatrics (#36 - tied), cardiology, heart, and vascular surgery (#35-tied), and neurology and neurosurgery (#31). A special congratulations to the Department of Obstetrics and Gynecology, which achieved its highest-ever placement in the US News rankings, earning the No. 4 spot nationally and securing its first top five ranking. Congratulations to all HMFP physicians and staff whose clinical excellence, dedication, and commitment to our patients, communities, and one another are reflected in these prestigious honors. Click here for full coverage.

Harvard Medical Faculty Physicians
Aug 6th, 2026
BIDMC OB/GYN Program Ranked #4 in the Nation by U.S. News & World Report

BIDMC OB/GYN program ranked #4 in the nation by U.S. News & World Report. Beth Israel Deaconess Medical Center's (BIDMC) Department of Obstetrics and Gynecology has been ranked #4 in the nation for Obstetrics & Gynecology care in U.S. News & World Report's 2026-2027 Best Hospitals rankings. The department was also recognized as Nationally High Performing in Gynecologic Cancer Surgery. "This recognition belongs to our entire department. Every day, our team brings our core values of humanity, excellence, and equity to life through the care we provide," said Blair Wylie, MD, MPH, Chair of the Department of Obstetrics and Gynecology at BIDMC. "From routine care to the most complex needs, our patients trust us to be with them at every stage of their journey. It is a privilege to care for them, and they are the reason this work and this recognition are so meaningful." The U.S. News & World Report recognition is part of a broader showing for BIDMC in this year's rankings. The hospital placed among the top 50 hospitals nationwide in eight specialties, and was named the #3 best hospital in the Boston region and #3 best hospital in Massachusetts. Across its specialties and procedures and conditions, BIDMC received 20 high-performing ratings in total. U.S. News evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions for this year's rankings; fewer than half earned recognition in any of the 37 areas of care assessed. To determine the Best Hospitals rankings, U.S. News analyzed each hospital's performance using objective measures such as risk-adjusted mortality rates, preventable complications, and patient experience, drawing on data from more than 800 million patient care records. More information on the U.S. News & World Report Best Hospitals rankings, including the full specialty rankings and procedures and conditions methodologies, is available at health.usnews.com/best-hospitals.

Beth Israel Deaconess Medical Center
Aug 5th, 2026
Beth Israel Deaconess Medical Center nationally recognized by U.S. News & World Report.

Beth Israel Deaconess Medical Center nationally recognized by U.S. News & World Report. August 05, 2026 BIDMC named in top three hospitals in Massachusetts. Boston, MA - Beth Israel Deaconess Medical Center (BIDMC) has been recognized for its high-quality care by U.S. News & World Report's 2026-2027 Best Hospitals edition, placing in the top 50 hospitals nationwide in eight specialties. BIDMC was ranked in the top 10 nationwide for two of those specialties: obstetrics & gynecology and diabetes & endocrinology. BIDMC was also named as the #3 best hospital in the Boston Metro Area region and #3 best hospital in Massachusetts. "Being again nationally recognized by U.S. News & World Report reflects the high-quality care teams across BIDMC provide to patients and their families," said Pete Healy, president, BIDMC & divisional president, Metro Boston, Beth Israel Lahey Health. "I am thankful for the commitment of our physicians, nurses, and staff to excellent and compassionate care." The eight specialties that BIDMC received national rankings include: * Obstetrics & Gynecology * Diabetes & Endocrinology * Gastroenterology & GI surgery * Pulmonology & Lung surgery * Cancer Care * Neurology & Neurosurgery * Heart & Vascular * Geriatrics The hospital received 20 high-performing ratings across specialties and procedures & conditions, including aortic valve surgery; colon cancer surgery; ear, nose & throat surgery; gynecological cancer surgery; heart bypass surgery; heart failure; kidney failure; leukemia, lymphoma & myeloma; lung cancer surgery; prostate cancer surgery; stroke; and urology. U.S. News evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions; less than half earned recognition in any of those 37 areas of care. To determine the Best Hospitals, U.S. News analyzed each hospital's performance based on objective measures such as risk-adjusted mortality rates, preventable complications and patient experience. The Best Hospitals Specialty rankings methodology and Procedures & Conditions ratings methodology measure patient outcomes using data from over 800 million records of patient care. About Beth Israel Deaconess Medical Center. Beth Israel Deaconess Medical Center is a leading academic medical center, where extraordinary care is supported by high-quality education and research. BIDMC is a teaching affiliate of Harvard Medical School, and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox. Beth Israel Deaconess Medical Center is a part of Beth Israel Lahey Health, a healthcare system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,700 physicians and 39,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education. Director of Media Relations Sarah finlaw. Please note: The contact information above is for journalists and news media only. For patient care and all other inquiries, please contact your doctor or BIDMC directly.

Harvard Health Publishing
Jul 20th, 2026
Newly approved pill cuts LDL cholesterol levels by more than half.

Newly approved pill cuts LDL cholesterol levels by more than half. News briefs. July 20, 2026 * Reviewed by Robert H. Shmerling, MD, Senior Faculty Editor, Harvard Health Publishing; Editorial Advisory Board Member, Harvard Health Publishing A new pill that dramatically lowers harmful LDL cholesterol may be a good option for people who can't tolerate statins or who haven't lowered their LDL enough despite their current treatment with cholesterol-lowering drugs. Approved by the FDA in July 2026, enlicitide (Lipfendra) is the first oral version of a class of drugs known as PCSK9 inhibitors. These drugs work by mimicking the effect of a naturally occurring variant in the PCSK9 gene that leads to very low LDL levels. But the original drugs - which are given by injection once or twice a month - aren't widely used. Some people aren't comfortable giving themselves an injection. Also, most insurance companies won't cover the cost (which range from $200 to $500 or more per month) until a person has tried other therapies without success. Enlicitide is a daily pill that must be taken on an empty stomach with a sip of water, black coffee, or plain tea. It lowers LDL by nearly 60%, which is similar to the injectable PCSK9 drugs. Less than 10% of users experienced either dizziness or diarrhea, the two most common side effects. A month's supply will cost about $300; for now, insurance coverage remains unclear. You might also be interested in... Managing Your Cholesterol. Managing Your Cholesterol offers up-to-date information to help you or a loved one keep cholesterol in check. The report spells out what are healthy and unhealthy cholesterol levels, and offers specific ways to keep cholesterol in line. It covers cholesterol tests and the genetics of cholesterol. The report also focuses on treatments based on the latest scientific evidence, including the pros and cons of statins and other medications, and provides the lowdown on other substances advertised to lower cholesterol. Managing Your Cholesterol can also help you work with your doctor to individualize your treatment. The drug might be especially helpful for people whose LDL remains above recommended levels, despite taking cholesterol-lowering drug such as statins. The 2026 cholesterol guidelines recommend that people who've had a heart attack or stroke should aim for an LDL cholesterol of less than 55 milligrams per deciliter. The injectable PCSK9 drugs, alirocumab (Praluent) and evolocumab (Repatha), have been shown to reduce the incidence of heart attacks, strokes, and death from cardiovascular disease by up to 20% among people at high risk, over periods of up to at least five years. A similar study is currently underway to see if enlicitide offers the same benefit, with results expected in several years. Julie Corliss has been the executive editor of the Harvard Heart Letter since 2013. She also writes for the Harvard Health Letter, Harvard Women's Health Watch, and Harvard Men's Health Watch, as well as for Harvard... See Full Bio About the reviewer. Robert H. Shmerling, MD, Senior Faculty Editor, Harvard Health Publishing; Editorial Advisory Board Member, Harvard Health Publishing Dr. Robert H. Shmerling is the former clinical chief of the division of rheumatology at Beth Israel Deaconess Medical Center (BIDMC), and is a current member of the corresponding faculty in medicine at Harvard Medical School... See Full Bio Disclaimer: As a service to its readers, Harvard Health Publishing provides access to its library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.